Bone-Targeted Agents in Breast Cancer: Do We Now Have All the Answers?

Breast Cancer (Auckl) · 2019 · PMC6751527 · PMID 31555046

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This led to a meta-analysis of individual patient data from 18 766 patients treated with adjuvant BPs (predominantly ZA, clodronate, and ibandronate) and demonstrated a highly significant reduction in breast cancer mortality (death rate 0.82; 95% CI: 0.73-0.93) with BPs in postmenopausal women only.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.